Skip to main content

Closed

EOLS: Evolus, Inc. Stock Analysis | finqOS

Healthcare · Drug Manufacturers - Specialty & Generic

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-9.6%

ROIC-18.6%

Financially safe

Stretched

Debt / equity-5.73×

Interest coverage-1.5×

Current ratio2.04×

Evolus, Inc.

EOLSNASDAQ Global Market·USD·Closed

Evolus, Inc.

EOLSNASDAQ·USD·Closed

$5.84

−2.83%

$5.84

−$0.17 (2.83%)

52W Range

36thpctl

Volume

0.73×avg

Mkt Cap

384.59MUSD

P/E

-8.7TTM

Div Yield

–ann

52W Range

36thpctl

Volume

0.73×avg

Market Cap

384.59MUSD

P/E Ratio

-8.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings